МicroRNA as promising biomarkers of obesity comorbidities in childhood
- 16 November 2026
- journal article
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (5)
Abstract
The growing number of obese children creates the need to find modern indicators for the early detection of concomitant diseases. Candidates for the role of biomarkers may be microRNAs that naturally suppress gene expression. Objective. To present and summarize information about the features of microRNA expression in children with obesity and comorbid pathology. Materials and methods. The results of studies on the assessment of microRNA expression in childhood obesity complications were searched using Scopus, Web of Science, PubMed, Google Scholar, eLibrary, and Cyberleninka databases. Results. Studies on endothelial dysfunction in childhood obesity have identified microRNAs-320a and -630 as possible indicators of diagnosis and treatment. The search for alternative markers for the diagnosis of metabolic dysfunction-associated steatotic liver disease has revealed the value of several signaling molecules (microRNAs-199a-5p, -22, -122, -486, -146b and -15b), which can also be used to assess the risk of type 2 mellitus, metabolic syndrome and insulin resistance in children. No significant relationship has been established between the studied microRNAs and atherosclerosis. Conclusion. MicroRNAs are promising prognostic markers for the early detection of endothelial dysfunction, metabolic associated steatotic liver disease, type 2 diabetes, metabolic syndrome, and insulin resistance in obese children.This publication has 39 references indexed in Scilit:
- MicroRNAs as the promising markers of comorbidities in childhood obesity—A systematic reviewPediatric Obesity, 2021
- Methodological considerations for measuring biofluid-based microRNA biomarkersCritical Reviews in Toxicology, 2021
- Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patientsInternational Journal of Obesity, 2021
- Peripheral arterial tonometry as a method of measuring reactive hyperaemia correlates with organ dysfunction and prognosis in the critically ill patient: a prospective observational studyJournal of Clinical Monitoring and Computing, 2020
- Circulating microRNAs and adipokines as markers of metabolic syndrome in adolescents with obesityClinical Nutrition, 2019
- Improvement of microvascular endothelial dysfunction induced by exercise and diet is associated with microRNA-126 in obese adolescentsMicrovascular Research, 2019
- Childhood obesity, weight loss and developmental trajectories predict the persistence and remission of childhood sleep‐disordered breathingPediatric Obesity, 2018
- Change in circulating microRNA profile of obese children indicates future risk of adult diabetesMetabolism, 2018
- Circulating levels of miR‐122 and nonalcoholic fatty liver disease in pre‐pubertal obese childrenPediatric Obesity, 2017
- Elevation of circulating microRNA levels in obese children compared to healthy controlsClinical Obesity, 2017